DnB Asset Management AS trimmed its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 69.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,842 shares of the company's stock after selling 24,937 shares during the period. DnB Asset Management AS's holdings in Molina Healthcare were worth $3,156,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in MOH. Public Sector Pension Investment Board increased its stake in shares of Molina Healthcare by 13.5% in the third quarter. Public Sector Pension Investment Board now owns 2,527 shares of the company's stock valued at $871,000 after purchasing an additional 300 shares during the period. Tributary Capital Management LLC lifted its position in shares of Molina Healthcare by 76.1% in the 4th quarter. Tributary Capital Management LLC now owns 4,190 shares of the company's stock valued at $1,219,000 after acquiring an additional 1,811 shares in the last quarter. Everence Capital Management Inc. purchased a new stake in Molina Healthcare in the 4th quarter worth about $544,000. Smartleaf Asset Management LLC boosted its stake in shares of Molina Healthcare by 123.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock valued at $100,000 after buying an additional 192 shares during the period. Finally, SYM FINANCIAL Corp acquired a new position in Molina Healthcare in the 4th quarter worth about $249,000. Institutional investors and hedge funds own 98.50% of the company's stock.
Analyst Ratings Changes
Several equities analysts have commented on MOH shares. UBS Group lowered their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. JPMorgan Chase & Co. restated a "neutral" rating and set a $350.00 target price (down previously from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Wells Fargo & Company raised shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. Truist Financial decreased their price objective on shares of Molina Healthcare from $370.00 to $340.00 and set a "buy" rating on the stock in a report on Wednesday, February 19th. Finally, Barclays cut their target price on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a report on Friday, February 7th. Six analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Molina Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $348.75.
Check Out Our Latest Report on Molina Healthcare
Insiders Place Their Bets
In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.10% of the company's stock.
Molina Healthcare Stock Performance
NYSE MOH traded up $0.56 on Wednesday, hitting $328.27. 384,080 shares of the stock traded hands, compared to its average volume of 634,557. The firm has a market capitalization of $17.96 billion, a price-to-earnings ratio of 16.07, a PEG ratio of 1.06 and a beta of 0.56. The business's fifty day moving average is $304.95 and its two-hundred day moving average is $308.51. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a 12 month low of $262.32 and a 12 month high of $384.35.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. As a group, equities analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.